Federal Contractor Profile
Phlow Corp.
Federal contracting record: $703M obligated across 4 awards from 2 agencies, FY 2020–2026.
Company Profile
UEI (Unique Entity Identifier)
ZZN7NVV7JKG9
CAGE Code
8HXQ3
Parent Organization
Phlow Corp.
Address
737 N 5TH ST STE 605, RICHMOND, VA, 232191441
First Federal Award
Apr 23, 2020
Most Recent Award
Mar 3, 2026
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- $703M
Department of Health and Human Services
100.0% of total obligations
- $0
Department of Veterans Affairs
0.0% of total obligations
Top NAICS Activity
- $697M
325412
PHARMACEUTICAL PREPARATION MANUFACTURING
3 awards
- $6.0M
424210
DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS
1 awards
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Jan 26, 2026 | Department of Health and Human ServicesASPR/DAAPPO/ORM HQ | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $26M |
| Jan 26, 2026 | Department of Health and Human ServicesASPR/DAAPPO/ORM HQ | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $54M |
| Nov 4, 2025 | Department of Health and Human ServicesASPR/DAAPPO/ORM HQ | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $25M |
| Sep 30, 2025 | Department of Health and Human ServicesASPR/DAAPPO/ORM HQ | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $8.4M |
| Sep 30, 2024 | Department of Health and Human ServicesASPR/DAAPPO/ORM HQ | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $7.1M |
| Sep 29, 2024 | Department of Health and Human ServicesASPR/DAAPPO/ORM HQ | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $3.9M |
| Sep 18, 2024 | Department of Health and Human ServicesASPR/DAAPPO/ORM HQ | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $52M |
| Sep 11, 2024 | Department of Health and Human ServicesASPR/DAAPPO/ORM HQ | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $9.9M |
| Aug 28, 2024 | Department of Health and Human ServicesASPR/DAAPPO/ORM HQ | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $7.7M |
| Jul 3, 2024 | Department of Health and Human ServicesASPR/DAAPPO/ORM HQ | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $10M |
| Sep 26, 2023 | Department of Health and Human ServicesASPR/DAAPPO/ORM HQ | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $51M |
| Dec 21, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $87M |
| May 18, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 325412 | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | $354M |
| Apr 23, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 424210 | COVID-19 ESSENTIAL API AND MEDICINES | $6.0M |
Related Contractors
Other companies active in NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING.
Track Phlow Corp. Recompetes Before They Post
Mindy monitors Phlow Corp.'s active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.
Get Free Recompete Alerts